Abstract
Blood pressure has a significant genetic component, but less than 3% of the observed variance has been attributed to genetic variants identified to date. Candidate gene studies of rare, monogenic hypertensive syndromes have conclusively implicated several genes altering renal sodium balance, and studies of essential hypertension have inconsistently implicated over 50 genes in pathways affecting renal sodium balance and other functions. Genome-wide linkage scans have replicated numerous quantitative trait loci throughout the genome, and over 50 single nucleotide polymorphisms (SNPs) have been replicated in multiple genome-wide association studies. These studies provide considerable evidence that epistasis and other interactions play a role in the genetic architecture of blood pressure regulation, but candidate gene studies have limited scope to test for epistasis, and genome-wide studies have low power for both main effects and interactions. This review summarizes the genetic findings to date for blood pressure, and it proposes focused, pathway-based approaches involving epistasis, gene-environment interactions, and next-generation sequencing to further the genetic dissection of blood pressure and hypertension.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
National Center for Health Statistics. Health, United States, 2010: with special feature on death and dying. Hyattsville, MD2011.
Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–92.
• Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep. 2010;12(1):17-25. This review of all BP GWAS through 2010 describes the significance and interpretation of the findings in these studies.
Platt R. The nature of essential hypertension. Lancet. 1959;2(7091):55–7.
Pickering G. High blood pressure. London: J & A. Churchill; 1955.
Milford DV. Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child. 1999;81(5):452–5.
Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens. 2005;23(12):2127–43.
Charchar F, Zimmerli L, Tomaszewski M. The pressure of finding human hypertension genes: new tools, old dilemmas. J Hum Hypertens. 2008;22(12):821–8.
Pascoe L, Curnow KM, Slutsker L, Rosler A, White PC. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A. 1992;89(11):4996–5000.
Wang X, Zhu H, Dong Y, Treiber FA, Snieder H. Effects of angiotensinogen and angiotensin II type I receptor genes on blood pressure and left ventricular mass trajectories in multiethnic youth. Twin Res Hum Genet. 2006;9(3):393–402.
Tsai CT, Fallin D, Chiang FT, Hwang JJ, Lai LP, Hsu KL, et al. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension. 2003;41(1):9–15.
Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001;68(5):1139–48.
Reich H, Duncan JA, Weinstein J, Cattran DC, Scholey JW, Miller JA. Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int. 2003;63(4):1443–9.
Williams SM, Ritchie MD, Phillips 3rd JA, Dawson E, Prince M, Dzhura E, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004;57(1):28–38.
Wang JG, Staessen JA, Barlassina C, Fagard R, Kuznetsova T, Struijker-Boudier HA, et al. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Kidney Int. 2002;62(6):2152–9.
Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, et al. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens. 2004;22(5):937–44.
Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19(8):1349–58.
Baker EH, Dong YB, Sagnella GA, Rothwell M, Onipinla AK, Markandu ND, et al. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet. 1998;351(9113):1388–92.
Ji W, Foo JN, O’Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40(5):592–9.
Tanira MO, Al Balushi KA. Genetic variations related to hypertension: a review. J Hum Hypertens. 2005;19(1):7–19.
Bianchi G. Genetic variations of tubular sodium reabsorption leading to “primary” hypertension: from gene polymorphism to clinical symptoms. Am J Physiol Regul Integr Comp Physiol. 2005;289(6):R1536–49.
Citterio L, Lanzani C, Manunta P, Bianchi G. Genetics of primary hypertension: the clinical impact of adducin polymorphisms. Biochim Biophys Acta. 2010;1802(12):1285–98.
Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38(3):399–403.
Panoulas VF, Douglas KM, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, et al. Transforming growth factor-beta1 869T/C, but not interleukin-6–174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology (Oxford). 2009;48(2):113–8.
He F, Zhao D, Deng F, Zhong H, Shi X, Yang J, et al. Association of TGF-beta1 gene polymorphisms in exon1 and blood levels with essential hypertension. Blood Press. 2010;19(4):225–33.
Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, et al. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension. 2001;38(3):303–8.
Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, et al. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest. 1998;102:493–8.
Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, et al. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension. 2006;47(2):288–95.
Ramirez-Lorca R, Grilo A, Martinez-Larrad MT, Manzano L, Serrano-Hernando FJ, Moron FJ, et al. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension. 2007;50(5):884–90.
Taylor JY, Sun YV, Hunt SC, Kardia SL. Gene-environment interaction for hypertension among African American women across generations. Biol Res Nurs. 2010;12(2):149–55.
Taylor J, Sun YV, Chu J, Mosley TH, Kardia SL. Interactions between metallopeptidase 3 polymorphism rs679620 and BMI in predicting blood pressure in African-American women with hypertension. J Hypertens. 2008;26(12):2312–8.
Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, et al. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension. 2003;42(4):685–92.
Pan X, Liu Y, Zhang Y, Zhang X, Xu Q, Tong W. Interaction of the C-344T polymorphism of CYP11b2 gene with body mass index and waist circumference affecting diastolic blood pressure in Chinese Mongolian population. Blood Press. 2010;19(6):373–9.
Fava C, Montagnana M, Almgren P, Rosberg L, Guidi GC, Berglund G, et al. Association between adducin-1 G460W variant and blood pressure in Swedes is dependent on interaction with body mass index and gender. Am J Hypertens. 2007;20(9):981–9.
Montasser ME, Gu D, Chen J, Shimmin LC, Gu C, Kelly TN, et al. Interactions of genetic variants with physical activity are associated with blood pressure in Chinese: The GenSalt Study. Am J Hypertens. 2011;24(9):1035–40.
Bowden DW, An SS, Palmer ND, Brown WM, Norris JM, Haffner SM, et al. Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. Hum Mol Genet. 2010;19(20):4112–20.
•• Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-53. This review describes the state of complex trait genetics for several traits and discusses the possible sources of unexplained heritability.
Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol. 2007;22(3):176–84.
Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, et al. Genome-wide mapping of human loci for essential hypertension. Lancet. 2003;361(9375):2118–23.
Munroe PB, Wallace C, Xue MZ, Marcano AC, Dobson RJ, Onipinla AK, et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension. 2006;48(1):105–11.
Rao DC, Province MA, Leppert MF, Oberman A, Heiss G, Ellison RC, et al. A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network. Am J Hypertens. 2003;16(2):148–50.
Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, et al. A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2003;16(2):144–7.
Chang YP, Liu X, Kim JD, Ikeda MA, Layton MR, Weder AB, et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet. 2007;80(2):253–64.
Perola M, Kainulainen K, Pajukanta P, Terwilliger JD, Hiekkalinna T, Ellonen P, et al. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens. 2000;18(11):1579–85.
Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension. 2002;40(1):1–6.
James K, Weitzel LR, Engelman CD, Zerbe G, Norris JM. Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet. 2003;4 Suppl 1:S83.
DiPetrillo K, Tsaih SW, Sheehan S, Johns C, Kelmenson P, Gavras H, et al. Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice. Physiol Genomics. 2004;17(2):215–20.
Puppala S, Coletta DK, Schneider J, Hu SL, Farook VS, Dyer TD, et al. Genome-wide linkage screen for systolic blood pressure in the Veterans Administration Genetic Epidemiology Study (VAGES) of Mexican-Americans and confirmation of a major susceptibility locus on chromosome 6q14.1. Hum Hered. 2011;71(1):1–10.
Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension. 2001;38(4):773–8.
Yang HC, Liang YJ, Wu YL, Chung CM, Chiang KM, Ho HY, et al. Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS One. 2009;4(5):e5459.
Cowley Jr AW. The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7(11):829–40.
Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, Kaldunski M, et al. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet. 2005;76(5):815–32.
Ciullo M, Bellenguez C, Colonna V, Nutile T, Calabria A, Pacente R, et al. New susceptibility locus for hypertension on chromosome 8q by efficient pedigree-breaking in an Italian isolate. Hum Mol Genet. 2006;15(10):1735–43.
Simino J, Shi G, Kume R, Schwander K, Province MA, Gu CC, et al. Five blood pressure loci identified by an updated genome-wide linkage scan: meta-analysis of the Family Blood Pressure Program. Am J Hypertens. 2011;24(3):347–54.
Bell JT, Wallace C, Dobson R, Wiltshire S, Mein C, Pembroke J, et al. Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum Mol Genet. 2006;15(8):1365–74.
Fung MM, Zhang K, Zhang L, Rao F, O’Connor DT. Contemporary approaches to genetic influences on hypertension. Curr Opin Nephrol Hypertens. 2011;20(1):23–30.
Shi G, Gu CC, Kraja AT, Arnett DK, Myers RH, Pankow JS, et al. Genetic effect on blood pressure is modulated by age: the Hypertension Genetic Epidemiology Network Study. Hypertension. 2009;53(1):35–41.
Vidan-Jeras B, Gregoric A, Jurca B, Jeras M, Bohinjec M. Possible influence of genes located on chromosome 6 within or near to the major histocompatibility complex on development of essential hypertension. Pflugers Arch. 2000;439(3 Suppl):R60–2.
Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, et al. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension. 2000;36(1):14–9.
Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 2009;5(7):e1000564.
Adeyemo A, Luke A, Wu X, Cooper RS, Kan D, Omotade O, et al. Genetic effects on blood pressure localized to chromosomes 6 and 7. J Hypertens. 2005;23(7):1367–73.
Nadar SK, Blann AD, Lip GY. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy. J Intern Med. 2004;256(4):331–7.
Jacobs KB, Gray-McGuire C, Cartier KC, Elston RC. Genome-wide linkage scan for genes affecting longitudinal trends in systolic blood pressure. BMC Genet. 2003;4 Suppl 1:S82.
Barbalic M, Narancic NS, Skaric-Juric T, Salihovic MP, Klaric IM, Lauc LB, et al. A quantitative trait locus for SBP maps near KCNB1 and PTGIS in a population isolate. Am J Hypertens. 2009;22(6):663–8.
Iwai N, Katsuya T, Ishikawa K, Mannami T, Ogata J, Higaki J, et al. Human prostacyclin synthase gene and hypertension: the Suita Study. Circulation. 1999;100(22):2231–6.
Rutherford S, Cai G, Lopez-Alvarenga JC, Kent JW, Voruganti VS, Proffitt JM, et al. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study. Am J Hum Genet. 2007;81(4):744–55.
Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, Chen C, et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet. 1999;64(6):1694–701.
Zhu X, Luke A, Cooper RS, Quertermous T, Hanis C, Mosley T, et al. Admixture mapping for hypertension loci with genome-scan markers. Nat Genet. 2005;37(2):177–81.
Zhu X, Cooper RS. Admixture mapping provides evidence of association of the VNN1 gene with hypertension. PLoS One. 2007;2(11):e1244.
Ding K, Feng D, de Andrade M, Mosley Jr TH, Turner ST, Boerwinkle E, et al. Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships. J Hum Hypertens. 2008;22(2):102–10.
Franceschini N, Reiner AP, Heiss G. Recent findings in the genetics of blood pressure and hypertension traits. Am J Hypertens. 2011;24(4):392–400.
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.
Rafiqi FH, Zuber AM, Glover M, Richardson C, Fleming S, Jovanovic S, et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med. 2010;2(2):63–75.
Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ, et al. Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet. 2007;8 Suppl 1:S3.
Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet. 2009;18(12):2288–96.
Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nat Genet. 2007;39(7):813–5.
Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009;41(5):527–34.
Hong KW, Go MJ, Jin HS, Lim JE, Lee JY, Han BG, et al. Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and/or hypertension in two Korean cohorts. J Hum Hypertens. 2010;24(6):367–72.
Hiura Y, Tabara Y, Kokubo Y, Okamura T, Miki T, Tomoike H, et al. A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circ J. 2010;74(11):2353–9.
Wang Y, O’Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A. 2009;106(1):226–31.
Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics. 2008;92(5):265–72.
Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, Musani SK, et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet. 2011;20(11):2273–84.
Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet. 2009;41(1):35–46.
Gu CC, Chang YP, Hunt SC, Schwander K, Arnett D, Djousse L, et al. Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered. 2005;60(3):164–76.
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41(6):666–76.
Ho JE, Levy D, Rose L, Johnson AD, Ridker PM, Chasman DI. Discovery and replication of novel blood pressure genetic loci in the Women’s Genome Health Study. J Hypertens. 2011;29(1):62–9.
Hong KW, Jin HS, Lim JE, Kim S, Go MJ, Oh B. Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population. J Hum Genet. 2010;55(6):336–41.
Takeuchi F, Isono M, Katsuya T, Yamamoto K, Yokota M, Sugiyama T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation. 2010;121(21):2302–9.
Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet. 2011;43(6):531–8.
• Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103-9. This account of a meta-GWAS for blood pressure with 200,000 subjects in the replication sample reported several novel loci and replicated them, as well as replicating several known blood pressure loci.
• Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD, et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43(10):1005-11. This meta-GWAS for pulse pressure and mean arterial pressure had 48,000 subjects in the replication sample.
Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 2010;6(10):e1001177.
Wang X, Snieder H. Genome-wide association studies and beyond: what’s next in blood pressure genetics? Hypertension. 2010;56(6):1035–7.
•• Harrap SB. Blood pressure genetics: time to focus. J Am Soc Hypertens. 2009;3(4):231-7. This is a review of the 2007 meta-GWAS findings (CHARGE and GlobalBPgen). The author argues for a focused approach to determine the precise DNA variants and their mechanisms for known BP loci, rather than expanding GWAS for even smaller effects.
Deng AY. Genetic basis of polygenic hypertension. Hum Mol Genet. 2007;16(Spec No. 2):R195–202.
Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 2001;69(1):124–37.
A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-73.
Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, et al. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension. 2008;51(6):1643–50.
Yeh TK, Yeh TC, Weng CF, Shih BF, Tsao HJ, Hsiao CH, et al. Association of polymorphisms in genes involved in the dopaminergic pathway with blood pressure and uric acid levels in Chinese females. J Neural Transm. 2010;117(12):1371–6.
Weng L, Macciardi F, Subramanian A, Guffanti G, Potkin SG, Yu Z, et al. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011;12:99.
Zuo Y, Kang G. A mixed two-stage method for detecting interactions in genomewide association studies. J Theor Biol. 2010;262(4):576–83.
Shi G, Simino J, Rao DC. Enriching rare variants using family-specific linkage information. GAW 17 . BMC Proceedings. 2011.
Shi G, Rao DC. Optimum designs for next-generation sequencing to discover rare variants for common complex disease. Genet Epidemiol. 2011;35(6):572–9.
Gloyn AL, McCarthy MI. Variation across the allele frequency spectrum. Nat Genet. 2010;42(8):648–50.
Zeggini E. Next-generation association studies for complex traits. Nat Genet. 2011;43(4):287–8.
Holm H, Gudbjartsson DF, Sulem P, Masson G, Helgadottir HT, Zanon C, et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet. 2011;43(4):316–20.
Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation. 2005;112(22):3423–9.
Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007;81(2):405–13.
Campion J, Milagro F, Martinez JA. Epigenetics and obesity. Prog Mol Biol Transl Sci. 2010;94:291–347.
Mathers JC, Mckay JA. Diet induced epigenetic changes and their implications for health. Acta Physiologica. 2011;202(2):103–18.
Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet. 2010;11(6):415–25.
Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, et al. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355(6357):262–5.
Amor M, Parker KL, Globerman H, New MI, White PC. Mutation in the CYP21B gene (Ile-172→Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 1988;85(5):1600–4.
Funder J, Pearce P, Smith R, Smith A. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1987;242:583–5.
Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 1979;49(5):757–64.
Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest. 1991;87(2):680–6.
White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A. A mutation in CYP11B1 (Arg-448→His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest. 1991;87(5):1664–7.
Kagimoto M, Winter JS, Kagimoto K, Simpson ER, Waterman MR. Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency. Mol Endocrinol. 1988;2(6):564–70.
Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289(5476):119–23.
Hanukoglu A, Type I. pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab. 1991;73(5):936–44.
Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. 1996;12(3):248–53.
Strautnieks SS, Thompson RJ, Gardiner RM, Chung E. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet. 1996;13(2):248–50.
Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293(5532):1107–12.
Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79(3):407–14.
Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11(1):76–82.
Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12(1):24–30.
Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13(2):183–8.
Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, et al. Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+channel, ROMK. Nat Genet. 1996;14(2):152–6.
Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet. 1997;17(2):171–8.
Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999;402(6764):880–3.
Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science. 2004;306(5699):1190–4.
Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, et al. Haplotype analysis of the human renin gene and essential hypertension. Hypertension. 2003;41(2):308–12.
Ahmad U, Saleheen D, Bokhari A, Frossard PM. Strong association of a renin intronic dimorphism with essential hypertension. Hypertens Res. 2005;28(4):339–44.
Johnson AD, Newton-Cheh C, Chasman DI, Ehret GB, Johnson T, Rose L, et al. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension. 2011;57(5):903–10.
Jeunemaitre X, Rigat B, Charru A, Houot AM, Soubrier F, Corvol P. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet. 1992;88(3):301–6.
Fu Y, Katsuya T, Asai T, Fukuda M, Inamoto N, Iwashima Y, et al. Lack of correlation between Mbo I restriction fragment length polymorphism of renin gene and essential hypertension in Japanese. Hypertens Res. 2001;24(3):295–8.
Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23(7):1269–75.
Province MA, Boerwinkle E, Chakravarti A, Cooper R, Fornage M, Leppert M, et al. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens. 2000;18(7):867–76.
van Rijn MJ, Schut AF, Aulchenko YS, Deinum J, Sayed-Tabatabaei FA, Yazdanpanah M, et al. Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J Hypertens. 2007;25(3):565–70.
Arfa I, Nouira S, Abid A, Bouafif-Ben Alaya N, Zorgati MM, Malouche D, et al. Lack of association between renin-angiotensin system (RAS) polymorphisms and hypertension in Tunisian type 2 diabetics. Tunis Med. 2010;88(1):38–41.
Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation. 1998;97(18):1773–9.
Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TI, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997;95(10):2358–67.
Staessen JA, Wang J, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting-enzyme and cardiovascular-renal risk. J Hypertens. 1997;15:1579–92.
Matsubara M, Suzuki M, Fujiwara T, Kikuya M, Metoki H, Michimata M, et al. Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study. J Hypertens. 2002;20(6):1121–6.
Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24(1):63–9.
Miyamoto Y, Yoshimasa T, Itoh H, Igaki T, Harda M, Yamashita J, et al. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension in Japanese. J Hypertens. 1996;14:S29.
Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet. 1997;51(1):31–4.
Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension. 1996;28(6):1076–80.
Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens. 1998;11(3 Pt 1):316–21.
Zhang X, Erdmann J, Regitz-Zagrosek V, Kurzinger S, Hense HW, Schunkert H. Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens. 2000;18(3):267–72.
Melander O, Orho-Melander M, Bengtsson K, Lindblad U, Rastam L, Groop L, et al. Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman’s syndrome and primary hypertension. Hypertension. 2000;36(3):389–94.
Song Y, Herrera VL, Filigheddu F, Troffa C, Lopez LV, Glorioso N, et al. Non-association of the thiazide-sensitive Na, Cl-cotransporter gene with polygenic hypertension in both rats and humans. J Hypertens. 2001;19(9):1547–51.
Kokubo Y, Kamide K, Inamoto N, Tanaka C, Banno M, Takiuchi S, et al. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet. 2004;49(9):507–15.
Chang PY, Zhang XG, Su XL. Lack of association of variants of the renal salt reabsorption-related genes SLC12A3 and ClC-Kb and hypertension in Mongolian and Han populations in Inner Mongolia. Genet Mol Res. 2011;10(2):948–54.
Glorioso N, Filigheddu F, Troffa C, Soro A, Parpaglia PP, Tsikoudakis A, et al. Interaction of alpha(1)-Na, K-ATPase and Na, K,2Cl-cotransporter genes in human essential hypertension. Hypertension. 2001;38(2):204–9.
Iwai N, Tago N, Yasui N, Kokubo Y, Inamoto N, Tomoike H, et al. Genetic analysis of 22 candidate genes for hypertension in the Japanese population. J Hypertens. 2004;22(6):1119–26.
Tobin MD, Tomaszewski M, Braund PS, Hajat C, Raleigh SM, Palmer TM, et al. Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension. 2008;51(6):1658–64.
Iwai N, Kajimoto K, Kokubo Y, Tomoike H. Extensive genetic analysis of 10 candidate genes for hypertension in Japanese. Hypertension. 2006;48(5):901–7.
Han Y, Fan X, Sun K, Wang X, Wang Y, Chen J, et al. Hypertension associated polymorphisms in WNK1/WNK4 are not associated with hydrochlorothiazide response. Clin Biochem. 2011;44(13):1045–9.
Putku M, Kepp K, Org E, Sober S, Comas D, Viigimaa M, et al. Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans. Hum Mutat. 2011;32(7):806–14.
Padmanabhan S, Menni C, Lee WK, Laing S, Brambilla P, Sega R, et al. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study. J Hypertens. 2010;28(3):465–77.
Benjafield AV, Katyk K, Morris BJ. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clin Genet. 2003;64(5):433–8.
Speirs HJ, Morris BJ. WNK4 intron 10 polymorphism is not associated with hypertension. Hypertension. 2004;43(4):766–8.
Busjahn A, Aydin A, Uhlmann R, Krasko C, Bahring S, Szelestei T, et al. Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension. 2002;40(3):256–60.
von Wowern F, Berglund G, Carlson J, Mansson H, Hedblad B, Melander O. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int. 2005;68(5):2164–72.
Lang F, Huang DY, Vallon V. SGK, renal function and hypertension. J Nephrol. 2010;23 Suppl 16:S124–9.
Trochen N, Ganapathipillai S, Ferrari P, Frey BM, Frey FJ. Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients. Nephrol Dial Transplant. 2004;19(10):2499–504.
Jin HS, Hong KW, Lim JE, Hwang SY, Lee SH, Shin C, et al. Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney Blood Press Res. 2010;33(1):15–23.
Jones ES, Owen EP, Davidson JS, Van Der Merwe L, Rayner BL. The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension. Cardiovasc J Afr. 2010;21:1–4.
Zhao Q, Gu D, Hixson JE, Liu DP, Rao DC, Jaquish CE, et al. Common variants in epithelial sodium channel genes contribute to salt sensitivity of blood pressure: the gensalt study. Circ Cardiovasc Genet. 2011;4(4):375–80.
Munroe PB, Strautnieks SS, Farrall M, Daniel HI, Lawson M, DeFreitas P, et al. Absence of linkage of the epithelial sodium channel to hypertension in black Caribbeans. Am J Hypertens. 1998;11(8 Pt 1):942–5.
Wang XF, Lu XM, Lin RY, Wang SZ, Zhang LP, Qian J, et al. Lack of association of functional variants in alpha-ENaC gene and essential hypertension in two ethnic groups in China. Kidney Blood Press Res. 2008;31(4):268–73.
Kokubo Y, Tomoike H, Tanaka C, Banno M, Okuda T, Inamoto N, et al. Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension. Hypertens Res. 2006;29(8):611–9.
Jung J, Sun B, Kwon D, Koller DL, Foroud TM. Allelic-based gene-gene interaction associated with quantitative traits. Genet Epidemiol. 2009;33(4):332–43.
Fava C, Montagnana M, Almgren P, Rosberg L, Guidi GC, Berglund G, et al. The functional variant of the CLC-Kb channel T481S is not associated with blood pressure or hypertension in Swedes. J Hypertens. 2007;25(1):111–6.
Cwynar M, Staessen JA, Ticha M, Nawrot T, Citterio L, Kuznetsova T, et al. Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. J Hypertens. 2005;23(5):961–9.
Busch CP, Harris SB, Hanley AJ, Zinman B, Hegele RA. The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree. J Hum Genet. 1999;44(4):225–9.
Shin MH, Chung EK, Kim HN, Park KS, Nam HS, Kweon SS, et al. Alpha-adducin Gly460Trp polymorphism and essential hypertension in Korea. J Korean Med Sci. 2004;19(6):812–4.
Niu WQ, Zhang Y, Ji KD, Gao PJ, Zhu DL. Lack of association between alpha-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J Hum Hypertens. 2010;24(7):467–74.
Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, et al. beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations. Am J Hypertens. 2003;16(10):840–6.
Kato N, Miyata T, Tabara Y, Katsuya T, Yanai K, Hanada H, et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum Mol Genet. 2008;17(4):617–27.
Sharma P, Hingorani A, Jia H, Ashby M, Hopper R, Clayton D, et al. Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension. 1998;32(4):676–82.
Jindra A, Jachymova M, Horky K, Peleska J, Umnerova V, Bultas J, et al. Association analysis of two tyrosine hydroxylase gene polymorphisms in normotensive offspring from hypertensive families. Blood Press. 2000;9(5):250–4.
Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension. 2000;36(2):183–6.
Lu Y, Zhu H, Wang X, Snieder H, Huang Y, Harshfield GA, et al. Effects of dopamine receptor type 1 and Gs protein alpha subunit gene polymorphisms on blood pressure at rest and in response to stress. Am J Hypertens. 2006;19(8):832–6.
Beige J, Bellmann A, Sharma AM, Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens. 2004;17(12 Pt 1):1184–7.
Orun O, Nacar C, Cabadak H, Tiber PM, Dogan Y, Guneysel O, et al. Investigation of the association between dopamine D1 receptor gene polymorphisms and essential hypertension in a group of turkish subjects. Clin Exp Hypertens. 2011;33(6):418–21.
Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the taq1 polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol. 2001;55:605–11.
Chi Htun N, Miyaki K, Song Y, Ikeda S, Shimbo T, Muramatsu M. Association of the Catechol-O-Methyl Transferase Gene Val158Met Polymorphism With Blood Pressure and Prevalence of Hypertension: Interaction With Dietary Energy Intake. Am J Hypertens. 2011;24(9):1022–6.
Abe M, Wu Z, Yamamoto M, Jin JJ, Tabara Y, Mogi M, et al. Association of dopamine beta-hydroxylase polymorphism with hypertension through interaction with fasting plasma glucose in Japanese. Hypertens Res. 2005;28(3):215–21.
Martinez Cantarin MP, Ertel A, Deloach S, Fortina P, Scott K, Burns TL, et al. Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin Transl Sci. 2010;3(6):279–86.
Lou Y, Liu J, Huang Y, Wang Z, Liu Y, Li Z, et al. A46G and C79G polymorphisms in the beta2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis. Hypertens Res. 2010;33(11):1114–23.
Gjesing AP, Sparso T, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T, et al. No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult Danes. PLoS One. 2009;4(9):e7206.
Gu D, Ge D, Snieder H, He J, Chen S, Huang J, et al. Association of alpha1A adrenergic receptor gene variants on chromosome 8p21 with human stage 2 hypertension. J Hypertens. 2006;24(6):1049–56.
Freitas SR, Pereira AC, Floriano MS, Mill JG, Krieger JE. Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population. BMC Cardiovasc Disord. 2008;8:40.
Xie HG, Kim RB, Stein CM, Gainer JV, Brown NJ, Wood AJ. Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics. 1999;9(5):651–6.
Peng Y, Xue H, Luo L, Yao W, Li R. Polymorphisms of the beta1-adrenergic receptor gene are associated with essential hypertension in Chinese. Clin Chem Lab Med. 2009;47(10):1227–31.
Gjesing AP, Andersen G, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, et al. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med. 2007;24(4):392–7.
Ringel J, Kreutz R, Distler A, Sharma AM. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am J Hypertens. 2000;13(9):1027–31.
Kitsios GD, Zintzaras E. Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database. Am J Hypertens. 2010;23(3):305–13.
Jemaa R, Kallel A, Sediri Y, Omar S, Feki M, Elasmi M, et al. Association between -786TC polymorphism in the endothelial nitric oxide synthase gene and hypertension in the Tunisian population. Exp Mol Pathol. 2011;90(2):210–4.
Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension. 1999;33(4):933–6.
Barath A, Endreffy E, Bereczki C, Gellen B, Szucs B, Nemeth I, et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension. Acta Physiol Hung. 2007;94(1–2):49–66.
Banno M, Hanada H, Kamide K, Kokubo Y, Kada A, Yang J, et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives. Hypertens Res. 2007;30(6):513–20.
Panoulas VF, Douglas KM, Smith JP, Taffe P, Stavropoulos-Kalinoglou A, Toms TE, et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium. 2008;15(4):203–12.
Wiltshire S, Powell BL, Jennens M, McCaskie PA, Carter KW, Palmer LJ, et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease. Hum Genet. 2008;123(3):307–13.
Rahman T, Baker M, Hall DH, Avery PJ, Keavney B. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family study. J Hum Hypertens. 2008;22(4):282–8.
Teh LK, Zahri MK, Zakaria ZA, Ismail R, Salleh MZ. Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography. J Clin Pharm Ther. 2010;35(6):723–8.
Dreisbach AW, Japa S, Sigel A, Parenti MB, Hess AE, Srinouanprachanh SL, et al. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension. Am J Hypertens. 2005;18(10):1276–81.
Acknowledgments
This research was supported by Grants R01 HL55673, U01 HL054473, U01 HL72507, R01 HL086694, and T32 HL083822 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. Helpful comments by Dr. Daniel O’Connor are greatly appreciated.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basson, J., Simino, J. & Rao, D.C. Between Candidate Genes and Whole Genomes: Time for Alternative Approaches in Blood Pressure Genetics. Curr Hypertens Rep 14, 46–61 (2012). https://doi.org/10.1007/s11906-011-0241-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-011-0241-8